Growing Points

  • Kenneth C. Calman
  • John F. Smyth
  • Martin H. N. Tattersall


The ideal drug for treating cancer would be one which was active when taken orally, which was capable of reaching every part of a tumour and eliminating even the most slowly dividing cells, and which was free of both acute and chronic side-effects. These conditions do not apply for any cancer drug currently prescribable, but several areas of research lead to justifiable optimism about future progress towards the desired selectivity of cancer chemotherapy.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Kenneth C. Calman, John F. Smyth and Martin H.N. Tattersall 1980

Authors and Affiliations

  • Kenneth C. Calman
    • 1
  • John F. Smyth
    • 2
  • Martin H. N. Tattersall
    • 3
    • 4
  1. 1.Cancer Research CampaignThe University of GlasgowUK
  2. 2.Imperial Cancer Research FundThe University of EdinburghUK
  3. 3.Sydney BranchLudwig Institute for Cancer ResearchAustralia
  4. 4.The University of SydneyAustralia

Personalised recommendations